Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Avalon Pharmaceuticals Inc (AVRX) since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data at Avalon Pharmaceuticals Inc. Table 2 shows the detailed insider transactions. The reporting company's CIK number is 1162192.
Total stock buying since 2005: $9,554,842.
Total stock sales since 2005: $5,191.
Total stock option exercises since 2005: $0.
▪ Recent SEC 13D filings for all companies
▪ Recent portfolio reports of all companies
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2008 | 4,832 | $12,307 | 2,032 | $5,191 | 0 | $0 |
| 2006 | 7,500 | $23,235 | 0 | $0 | 0 | $0 |
| 2005 | 906,600 | $9,519,300 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2008-01 | 4,832 | $12,307 | 2,032 | $5,191 | 0 | $0 |
| 2006-08 | 7,500 | $23,235 | 0 | $0 | 0 | $0 |
| 2005-10 | 906,600 | $9,519,300 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2008-01-23 | Carter Kenneth C (President and CEO) | Buy | 4,832 | 2.55 | 12,307 |
| 2008-01-17 | Carter Kenneth C (President and CEO) | Sale | 2,032 | 2.56 | 5,191 |
| 2006-08-30 | Carter Kenneth C (President and CEO) | Buy | 3,000 | 2.99 | 8,970 |
| 2006-08-28 | Hamilton J Michael (Chief Medical Officer) | Buy | 2,500 | 3.09 | 7,725 |
| 2006-08-22 | Carter Kenneth C (President and CEO) | Buy | 2,000 | 3.27 | 6,540 |
| 2005-10-04 | Beneden Patrick Van (Director) | Buy | 181,400 | 10.50 | 1,904,700 |
| 2005-10-04 | Euclidsr Partners, L.p. (Director) | Buy | 203,900 | 10.50 | 2,140,950 |
| 2005-10-04 | Whitaker Raymond J (Director) | Buy | 203,900 | 10.50 | 2,140,950 |
| 2005-10-04 | Adviesbeheer Gimv Life Sciences Nv (10% Owner) | Buy | 181,400 | 10.50 | 1,904,700 |
| 2005-10-04 | Royston Ivor (Director) | Buy | 136,000 | 10.50 | 1,428,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of AVRX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Avalon Pharmaceuticals Inc (symbol AVRX, CIK number 1162192) see the Securities and Exchange Commission (SEC) website.